Similar Search Results

Narrow search

Reference pricing of pharmaceuticals

Brekke, Kurt R. (contributor); … - 2006

Persistent link: https://www.econbiz.de/10003379831

Reference pricing of pharmaceuticals

Brekke, Kurt R.; Königbauer, Ingrid; Straume, Odd Rune - 2005

Persistent link: https://www.econbiz.de/10003278390

Reference pricing of pharmaceuticals

Brekke, Kurt R.; Königbauer, Ingrid; Straume, Odd Rune - 2006

We consider a therapeutic market with potentially three pharmaceutical firms. Two of the firms offer horizontally differentiated brand-name drugs. One of the brand-name drugs is a new treatment under patent protection that will be introduced if the profits are sufficient to cover the entry...

Persistent link: https://www.econbiz.de/10003393611

Reference pricing of pharmaceuticals

Brekke, Kurt R.; Königbauer, Ingrid; Straume, Odd Rune - In: Journal of health economics 26 (2007) 3, pp. 613-642

Persistent link: https://www.econbiz.de/10003459149

Reference pricing of pharmaceuticals

Brekke, Kurt R. (contributor); … - 2005

Persistent link: https://www.econbiz.de/10003241696

Reference Pricing of Pharmaceuticals

Brekke, Kurt Richard; Königbauer, Ingrid; Straume, Odd Rune - 2021

Persistent link: https://www.econbiz.de/10013317373

Advertising, generic competition and price regulation in pharmaceutical markets

Königbauer, Ingrid - In: CESifo economic studies : CESifo, a joint initiative of … 52 (2006) 3, pp. 565-586

The effect of price regulation on generic market entry and welfare in the presence of (persuasive) advertising is … analysed. An incumbent has the possibility to invest in advertising targeted at the physician. Advertising creates vertical …

Persistent link: https://www.econbiz.de/10003379146

Advertising and generic market entry

Königbauer, Ingrid - In: Journal of health economics 26 (2007) 2, pp. 286-305

Persistent link: https://www.econbiz.de/10003438049